Search

everythinglearnresearchcommunity

for

Search:↓

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Thallium poisoning from contaminated tortillas caused severe symptoms and was mostly fatal or led to long-term health issues.

Ancient DNA blocks are still present in human genomes, possibly due to advantages they provide.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Baricitinib was effective in treating both early and late onset alopecia areata.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Methotrexate's effectiveness for maintaining hair regrowth in alopecia totalis is unclear due to limited and biased data.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.